(Q35192203)

7 August 2017

1 reference

title

Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines (English)

1 reference

7 August 2017

1 reference

6

Rino Rappuoli

1 reference

7 August 2017

5

Mariagrazia Pizza

1 reference

7 August 2017

3

Mario Contorni

1 reference

7 August 2017

4

Maurizio Morandi

1 reference

7 August 2017

8

Giuseppe Del Giudice

1 reference

7 August 2017

7

Audino Podda

1 reference

7 August 2017

Samuele Peppoloni

1

1 reference

7 August 2017

Paolo Ruggiero

series ordinal

2

1 reference

7 August 2017

publication date

1 April 2003

1 reference

Expert Review of Vaccines

7 August 2017

published in

1 reference

7 August 2017

volume

2

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

285-293

1 reference

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Analysis of structure and function of the B subunit of cholera toxin by the use of site-directed mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

The comparison of the effect of LTR72 and MF59 adjuvants on mouse humoral response to intranasal immunisation with human papillomavirus type 6b (HPV-6b) virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Opinion: Interpretation of the complexity of innate immune responses by functional genomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.285

21 January 2018

Identifiers

DOI

10.1586/14760584.2.2.285

1 reference

7 August 2017

1 reference